7210 Research and experimental development on natural sciences and engineering

Established to develop novel approaches to the diagnosis and treatment of liver disorders, particularly Hepatitis C and liver fibrosis.

A leading medical imaging company that provides imaging biomarkers for clinical trials, research studies and diagnostics.

Provider of innovative solutions in the therapeutic areas of immunology, oncology and nephrology..

Developer of a unique proprietary drug discovery platform.

An orthopaedic imaging company specialising in the 3D analysis of human joints and human joint replacements.

Agro-biotech startup company that can dramatically increase crop productivity by using its breakthrough Enhanced Ploidy platform.

Aiming to make the treatment of inflammatory diseases and cancer more effective.

Provider of a full range of high-quality bioanalytical services.

Global leader in products and services to the laboratory life sciences and drug discovery markets.

Industrial biotechnology company developing novel new chemistry applied to building materials for energy efficiency.

A privately held UK company which has developed and patented technologies for use in microfluidic applications.

Clinical diagnostics and monitoring.

Ultra-accurate optical measurement and non-invasive diagnostics.

Developer of small molecule and monoclonal antibody therapeutics for inflammatory, autoimmune, and viral diseases, as well as for cancer applications.

Designs and develops high throughput mutagenesis technologies for studying functional genomics in mammalian systems.

Develops and markets biologic products for the repair or replacement of damaged or inadequate tissues.

A rapid integrator of cutting edge technology in functional genomics, proteomics, Bioinformatics and computational biology

Developer of minimally invasive therapies for obstructive sleep apnea.

Advancing disease-modifying technologies targeted at Alzheimer's, Parkinson's and other neurodegenerative diseases

An early stage biotechnology company

Supplier to the Life-Science Industries.

Developing Treatments for Rare Dermatologic Conditions

Developer of a novel platform technology for the diagnosis and treatment of various cancers as well as inflammatory diseases and heart disease.

Web-based provider of scientifically-tested brain training games

Clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases.

Developer of proprietary drug delivery nanotechnology.

Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases.

Creates and develops therapeutic products for cancer, autoimmune disease and other life-threatening and debilitating diseases.

A technology development company, focused on diagnostic and sensor technologies for laboratory and healthcare applications.

Biotechnology company focused on the research and development of innovative drugs to treat cancer and autoimmune diseases.

Global, late-stage focused clinical research organization (CRO) providing a comprehensive suite of clinical trial services.

Innovative healthy living, diabetes and pharmaceutical management company.

A specialist separation process development business which develops cost-saving applications.

Plant biotechnology company.

Dutch antibody company focused on the use of two proprietary technologies to build a pipeline of innovative human therapeutic antibodies: the Oligoclo

Provider of biomarker discovery and analysis

A spin-out company founded on the skills and expertise of the world-leading metabonomics research team at Imperial College London.

Clinical-stage biopharmaceutical company that develops novel therapeutics for cancer and infectious disease.

Radiation therapy company dedicated to advancing the treatment of cancer.

Vaccines for typhoid, travellers’ illnesses and hepatitis B Merged with NASDAQ listed Emergent Biosolutions Inc in July 2005.

An Imperial College spin out targeting the Allergy, Autoimmune, Infectious Disease and Influenza markets.

Developer of proprietary drugs for the treatment of gastrointestinal (GI) and systemic diseases.

A clinically-driven oncology company founded out of the former Amgen Institute

Separation/filtration equipment company.

Ddeveloper of cardiovascular and muscle disease therapeutics based on microRNA biology.

A biotechnology company, engages in the development and commercialization of microRNA (miRNA) therapeutics.

A specialist biotechnology company developing treatments for the management of life-threatening diseases.

Cell cycle / proliferation therapeutics company.